Physical fitness training for stroke patients (Review) - Update Software

More documents

Recommendations

Info

$Propofol versus thiopental sodium for the treatment of refractory ...$

Analysis 1.5. Comparison 1 Cardiorespiratory training versus control - end of intervention, Outcome 5 Risk factors - blood pressure, diastolic. Review: Physical fitness training for stroke patients Comparison: 1 Cardiorespiratory training versus control - end of intervention Outcome: 5 Risk factors - blood pressure, diastolic Study or subgroup Training Control Mean Difference Weight Mean Difference 1 During usual care N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI da Cunha 2002 6 95.33 (9.69) 6 94.33 (10.54) 5.3 % 1.00 [ -10.46, 12.46 ] Subtotal (95% CI) 6 6 5.3 % 1.00 [ -10.46, 12.46 ] Heterogeneity: not applicable Test for overall effect: Z = 0.17 (P = 0.86) 2 After usual care Katz-Leurer 2003 46 79 (9.7) 44 80.8 (10.2) 41.1 % -1.80 [ -5.92, 2.32 ] Lennon 2008 23 81.4 (8.4) 23 82 (9) 27.5 % -0.60 [ -5.63, 4.43 ] Potempa 1995 19 78.4 (9.15) 23 76.4 (7.67) 26.0 % 2.00 [ -3.17, 7.17 ] Subtotal (95% CI) 88 90 94.7 % -0.41 [ -3.12, 2.31 ] Heterogeneity: Tau 2 = 0.0; Chi 2 = 1.28, df = 2 (P = 0.53); I 2 =0.0% Test for overall effect: Z = 0.29 (P = 0.77) Total (95% CI) 94 96 100.0 % -0.33 [ -2.97, 2.31 ] Heterogeneity: Tau 2 = 0.0; Chi 2 = 1.33, df = 3 (P = 0.72); I 2 =0.0% Test for overall effect: Z = 0.25 (P = 0.81) Test for subgroup differences: Chi 2 = 0.05, df = 1 (P = 0.81), I 2 =0.0% Physical fitness training for stroke patients (Review) Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. -50 -25 0 25 50 Favours training Favours control 105
Analysis 1.6. Comparison 1 Cardiorespiratory training versus control - end of intervention, Outcome 6 Physical fitness - peak VO2 (ml/kg/min). Review: Physical fitness training for stroke patients Comparison: 1 Cardiorespiratory training versus control - end of intervention Outcome: 6 Physical fitness - peak VO2 (ml/kg/min) Study or subgroup Training Control Mean Difference Weight Mean Difference 1 During usual care N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI da Cunha 2002 6 11.55 (2.76) 6 8.12 (2.3) 21.6 % 3.43 [ 0.56, 6.30 ] Subtotal (95% CI) 6 6 21.6 % 3.43 [ 0.56, 6.30 ] Heterogeneity: not applicable Test for overall effect: Z = 2.34 (P = 0.019) 2 After usual care Lennon 2008 23 12 (2.2) 23 11.1 (1.9) 48.1 % 0.90 [ -0.29, 2.09 ] Moore 2010 10 18 (5.4) 10 16 (7.1) 7.7 % 2.00 [ -3.53, 7.53 ] Potempa 1995 19 18.8 (4.79) 23 15.2 (4.32) 22.5 % 3.60 [ 0.82, 6.38 ] Subtotal (95% CI) 52 56 78.4 % 1.78 [ -0.06, 3.62 ] Heterogeneity: Tau 2 = 1.06; Chi 2 = 3.11, df = 2 (P = 0.21); I 2 =36% Test for overall effect: Z = 1.90 (P = 0.058) Total (95% CI) 58 62 100.0 % 2.14 [ 0.50, 3.78 ] Heterogeneity: Tau 2 = 1.09; Chi 2 = 4.89, df = 3 (P = 0.18); I 2 =39% Test for overall effect: Z = 2.56 (P = 0.011) Test for subgroup differences: Chi 2 = 0.90, df = 1 (P = 0.34), I 2 =0.0% Physical fitness training for stroke patients (Review) Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. -4 -2 0 2 4 Favours control Favours training 106
Page 1 and 2:
Physical fitness training for strok
Page 3 and 4:
Analysis 1.19. Comparison 1 Cardior
Page 5 and 6:
Analysis 5.10. Comparison 5 Mixed t
Page 7 and 8:
Analysis 7.2. Comparison 7 Cardiore
Page 9 and 10:
walking speed (mean difference (MD)
Page 11 and 12:
Post-stroke physical activity and f
Page 13 and 14:
Search methods for identification o
Page 15 and 16:
• type of training (cardiorespira
Page 17 and 18:
Compliance with the scheduled exerc
Page 19 and 20:
Case fatality Number of deaths was
Page 21 and 22:
we did not include these data in th
Page 23 and 24:
(Flansbjer 2008; Kim 2001; Ouellett
Page 25 and 26:
data were, however, confounded by a
Page 27 and 28:
Vascular risk factors A few trials
Page 29 and 30:
ical function outcomes did not impr
Page 31 and 32:
We thank the Cochrane Stroke Group
Page 33 and 34:
or relaxation. Proceedings of the U
Page 35 and 36:
Dean 1997 {published data only} Dea
Page 37 and 38:
(LEAPS): a randomized controlled tr
Page 39 and 40:
with chronic stroke. Neurorehabilit
Page 41 and 42:
Askim {published data only} Askim T
Page 43 and 44:
Hobart 2002 Hobart JC, Williams LS,
Page 45 and 46:
andomized controlled trials. Clinic
Page 47 and 48:
Bale 2008 Methods Design: randomise
Page 49 and 50:
Cooke 2010 Methods Design: phase I
Page 51 and 52:
da Cunha 2002 Methods Design: rando
Page 53 and 54:
Duncan 1998 Methods Design: randomi
Page 55 and 56:
Eich 2004 Methods Design: randomise
Page 57 and 58:
Flansbjer 2008 (Continued) Allocati
Page 59 and 60:
James 2002 Methods Design: randomis
Page 61 and 62: Kim 2001 Methods Design: randomised
Page 63 and 64: Lennon 2008 Methods Design: pilot r
Page 65 and 66: Moore 2010 Methods Design: randomis
Page 67 and 68: Mudge 2009 (Continued) sessions (e.
Page 69 and 70: Pohl 2002 (Continued) Exclusion cri
Page 71 and 72: Richards 1993 (Continued) Intervent
Page 73 and 74: Salbach 2004 (Continued) Interventi
Page 75 and 76: Smith 2008 (Continued) Inclusion cr
Page 77 and 78: Winstein 2004 (Continued) sive hydr
Page 79 and 80: mAS: modified Ashworth Scale MAS: M
Page 81 and 82: (Continued) Franceschini 2009 Not v
Page 83 and 84: (Continued) Maeshima 2003 Not a rel
Page 85 and 86: (Continued) Thielman 2005 Not a rel
Page 87 and 88: Eng Trial name or title The effect
Page 89 and 90: Ivey (B) Trial name or title Streng
Page 91 and 92: Protas (Continued) Participants 48
Page 93 and 94: Suskin 2007 (Continued) Time frame:
Page 95 and 96: Wolff Trial name or title Effects o
Page 97 and 98: 11.2 After usual care 3 169 Mean Di
Page 99 and 100: 7 Physical fitness - maximum cyclin
Page 101 and 102: 10.2 After usual care 1 20 Mean Dif
Page 103 and 104: 13 Physical fitness - muscle streng
Page 105 and 106: 36 Mood - Hospital Anxiety and Depr
Page 107 and 108: 21.2 After usual care 1 80 Mean Dif
Page 109 and 110: Analysis 1.2. Comparison 1 Cardiore
Page 111: Analysis 1.4. Comparison 1 Cardiore
Page 117 and 118: Analysis 1.10. Comparison 1 Cardior
Page 151 and 152: Analysis 3.1. Comparison 3 Resisten
Page 161 and 162: Analysis 3.11. Comparison 3 Resiste
Page 163 and 164:
Analysis 4.1. Comparison 4 Resisten
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Analysis 5.1. Comparison 5 Mixed tr
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Analysis 7.2. Comparison 7 Cardiore
Page 233 and 234:
Table 1. Outline of the studies whi
Page 235 and 236:
Table 3. Outline of the studies whi
Page 237 and 238:
Table 4. Pooled walking data for ca
Page 239 and 240:
#42.(physical in Abstract and (exer
Page 241 and 242:
71 8 and 36 and 70 72 limit 71 to h
Page 243 and 244:
S58. (MH “Random Assignment”) o
Page 245 and 246:
W H A T ’ S N E W Last assessed a
Page 247:
MeSH check words Humans Physical fi
show all

Physical fitness training for stroke patients (Review) - Update Software

Create successful ePaper yourself

Delete template?

Save as template?